UBS Group’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,205
| Closed | -$20 | – | 11146 |
|
|
2025
Q1 | $20 | Sell |
3,205
-4,503
| -58% | -$41 | ﹤0.01% | 10093 |
|
|
2024
Q4 | $77 | Sell |
7,708
-749
| -9% | -$15 | ﹤0.01% | 9674 |
|
|
2024
Q3 | $178 | Buy |
8,457
+7,857
| +1,310% | +$240 | ﹤0.01% | 9090 |
|
|
2024
Q2 | $12 | Sell |
600
-80
| -12% | -$3 | ﹤0.01% | 9339 |
|
|
2024
Q1 | $24 | Buy |
680
+80
| +13% | +$5 | ﹤0.01% | 9017 |
|
|
2023
Q4 | $66 | Hold |
600
| – | – | ﹤0.01% | 8963 |
|
|
2023
Q3 | $72 | Sell |
600
-325
| -35% | -$39 | ﹤0.01% | 8946 |
|
|
2023
Q2 | $148 | Sell |
925
-245
| -21% | -$32 | ﹤0.01% | 8447 |
|
|
2023
Q1 | $176 | Sell |
1,170
-10,915
| -90% | -$2.15K | ﹤0.01% | 9154 |
|
|
2022
Q4 | $2.66K | Buy |
12,085
+10,333
| +590% | +$4.28K | ﹤0.01% | 9645 |
|
|
2022
Q3 | $1K | Sell |
1,752
-8,050
| -82% | -$5.47K | ﹤0.01% | 10072 |
|
|
2022
Q2 | $5K | Buy |
9,802
+4,859
| +98% | +$3.06K | ﹤0.01% | 8953 |
|
|
2022
Q1 | $4K | Buy |
4,943
+3,808
| +336% | +$3.92K | ﹤0.01% | 9335 |
|
|
2021
Q4 | $2K | Sell |
1,135
-1,942
| -63% | -$6.79K | ﹤0.01% | 9847 |
|
|
2021
Q3 | $21K | Sell |
3,077
-2,757
| -47% | -$14.9K | ﹤0.01% | 7122 |
|
|
2021
Q2 | $28K | Buy |
5,834
+4,049
| +227% | +$15K | ﹤0.01% | 7012 |
|
|
2021
Q1 | $5K | Buy |
+1,785
| New | +$3.6K | ﹤0.01% | 8344 |
|
|
2020
Q2 | – | Sell |
-490
| Closed | – | – | 8445 |
|
|
2020
Q1 | $0 | Buy |
490
+287
| +141% | +$229 | ﹤0.01% | 8514 |
|
|
2019
Q4 | $0 | Sell |
203
-14,097
| -99% | -$4.42K | ﹤0.01% | 8473 |
|
|
2019
Q3 | $5K | Buy |
14,300
+1,100
| +8% | +$375 | ﹤0.01% | 7500 |
|
|
2019
Q2 | $6K | Buy |
13,200
+100
| +0.8% | +$40 | ﹤0.01% | 7332 |
|
|
2019
Q1 | $5K | Hold |
13,100
| – | – | ﹤0.01% | 7195 |
|
|
2018
Q4 | $4K | Buy |
13,100
+8,700
| +198% | +$2.92K | ﹤0.01% | 7651 |
|
|
2018
Q3 | $2K | Sell |
4,400
-5,478
| -55% | -$2.72K | ﹤0.01% | 7761 |
|
|
2018
Q2 | $3K | Buy |
+9,878
| New | +$4.86K | ﹤0.01% | 7661 |
|
UBS Group's PAVMZ Position: Q2 2025 in Review
UBS Group sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q2 2025, closing a stake of 3,205 shares — an estimated $20 sold.
UBS Group first reported a position in PAVMZ in Q2 2018 and held it in 25 quarters. The position peaked at $28K in Q2 2021. 0 funds tracked by Wall St. Rank hold PAVMZ as of Q2 2025.
- UBS Group reported no remaining PAVmed Inc. Series Z Warrant position as of Q2 2025 after selling out during the quarter.
- UBS Group sold 3,205 PAVmed Inc. Series Z Warrant shares in Q2 2025, an estimated $20.
- UBS Group first reported a position in PAVmed Inc. Series Z Warrant in Q2 2018 and held it in 25 quarters.
- UBS Group's PAVmed Inc. Series Z Warrant position peaked at $28K in Q2 2021.
- 0 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q2 2025.
Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.